Immune Checkpoint Inhibitor-induced Sicca Syndrome

Samuel Bitoun¹, Antoine Rousseau², Marjolaine Gosset³, Rakiba Belkhir¹, Thierry Lazure⁴, Xavier Mariette¹, Gaetane Nocturne⁵

Affiliations

¹ Department of Rheumatology, Center for Immunology of Viral Infections and Autoimmune Diseases, Université Paris-Saclay, Hôpital Bicêtre, Assistance Publique - Hôpitaux de Paris, FHU CARE, INSERM UMR1184, 78, Avenue du General Leclerc, Le Kremlin Bicêtre 94270, France.
² Department of Ophthalmology, Université Paris-Saclay, Assistance Publique-Hôpitaux de Paris, Hôpital Bicetre, 78 Avenue du General Leclerc, Le Kremlin Bicêtre, 94270, France.
³ Laboratoire Orofacial Pathologies, Imaging and Biotherapies, URP2496, Université de Paris, Montrouge, France; Department of Oral Medicine / Dentistry, AP-HP, Hôpital Charles-Foix, 7 Avenue de La République, Ivry-sur-Seine, 94205, France.
⁴ Department of Pathology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Bicêtre, 78 Rue du Général Leclerc, Le Kremlin Bicêtre, 94270, France.
⁵ Department of Rheumatology, Center for Immunology of Viral Infections and Autoimmune Diseases, Université Paris-Saclay, Hôpital Bicêtre, Assistance Publique - Hôpitaux de Paris, FHU CARE, INSERM UMR1184, 78, Avenue du General Leclerc, Le Kremlin Bicêtre 94270, France. Electronic address: gaetane.nocturne@aphp.fr.

PMID: 38670727
DOI: 10.1016/j.rdc.2024.02.004

Review

Immune Checkpoint Inhibitor-induced Sicca Syndrome

Samuel Bitoun et al. Rheum Dis Clin North Am. 2024 May.

. 2024 May;50(2):291-300.

doi: 10.1016/j.rdc.2024.02.004.

Authors

Samuel Bitoun¹, Antoine Rousseau², Marjolaine Gosset³, Rakiba Belkhir¹, Thierry Lazure⁴, Xavier Mariette¹, Gaetane Nocturne⁵

Affiliations

¹ Department of Rheumatology, Center for Immunology of Viral Infections and Autoimmune Diseases, Université Paris-Saclay, Hôpital Bicêtre, Assistance Publique - Hôpitaux de Paris, FHU CARE, INSERM UMR1184, 78, Avenue du General Leclerc, Le Kremlin Bicêtre 94270, France.
² Department of Ophthalmology, Université Paris-Saclay, Assistance Publique-Hôpitaux de Paris, Hôpital Bicetre, 78 Avenue du General Leclerc, Le Kremlin Bicêtre, 94270, France.
³ Laboratoire Orofacial Pathologies, Imaging and Biotherapies, URP2496, Université de Paris, Montrouge, France; Department of Oral Medicine / Dentistry, AP-HP, Hôpital Charles-Foix, 7 Avenue de La République, Ivry-sur-Seine, 94205, France.
⁴ Department of Pathology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Bicêtre, 78 Rue du Général Leclerc, Le Kremlin Bicêtre, 94270, France.
⁵ Department of Rheumatology, Center for Immunology of Viral Infections and Autoimmune Diseases, Université Paris-Saclay, Hôpital Bicêtre, Assistance Publique - Hôpitaux de Paris, FHU CARE, INSERM UMR1184, 78, Avenue du General Leclerc, Le Kremlin Bicêtre 94270, France. Electronic address: gaetane.nocturne@aphp.fr.

PMID: 38670727
DOI: 10.1016/j.rdc.2024.02.004

Abstract

The development of sicca in patients treated with immune checkpoint inhibitors (ICIs) is undoubtedly an underestimated complication, but one whose functional consequences and impact on quality of life are significant for patients. This update aims to review the frequency of this complication and different clinical pictures. The authors also propose a diagnostic and therapeutic approach to guide clinicians in daily practice.

Keywords: Dryness; Immune checkpoint inhibitors; Immune-related adverse events; Sicca; Sjögren’s disease.

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors have nothing to disclose.

References

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- W.B. Saunders

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Immune Checkpoint Inhibitor-induced Sicca Syndrome

Affiliations

Immune Checkpoint Inhibitor-induced Sicca Syndrome

Authors

Affiliations

Abstract

Conflict of interest statement

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources